$ 19.09
Updated 20/08/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 2,183,824
High $ 19.35
Low $ 18.87
Open $ 19.19
ISIN
Prev close $ 19.09
# of shares 515.87M
Market cap 9,847.96M USD
Intraday

Market closed
Mylan N.V.
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  19.09 8.4% Stock price increasing 5.8% Stock price increasing -2.8% Stock price decreasing -38.9% Stock price decreasing -50.5% Stock price decreasing
Powered by TradingView

Company profile

Registered in the Netherlands, Mylan is a leading generic drugmaker, with roughly 55 manufacturing and R&D facilities. Although the company was formed in 1961, the company's position as the second- largest generic company was largely attributable to the acquisition of Matrix Laboratories and generics business of Germany-based Merck KGaA. Mylan has a portfolio of more than 7,500 generic, specialty, and over-the-counter active ingredients and medicines and is predominantly recognized for manufacturing the EpiPen (treatment for anaphylaxis), which was acquired through the Merk KGaA transaction.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 00:12:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB2 - 2019-08-22 01:12:40 - 2019-08-22 00:12:40 - 1000 - Website: OKAY